Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis

Published:2023-05-29 Issue:2 Volume:81 Page:231-245
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Rodriguez-Gutierrez Rene^ORCID,Garcia-Leal Mariana,Raygoza-Cortez Karina,Flores-Rodríguez Andrea,Moreno-Alvarado Marcela,Heredia-Martínez E. Maximiliano,Vazquez-Baquerizo Briana,Guerra-Espiricueta Raul,Muñoz-Silva Valeria,Gonzalez-Gonzalez Jose Gerardo

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03401-y.pdf

Reference56 articles.

1. W.B. Kannel, D.L. McGee, Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2, 120–126 (1979). https://doi.org/10.2337/DIACARE.2.2.120

2. C.S. Fox, S. Coady, P.D. Sorlie, D. Levy, J.B. Meigs, R.B. D’Agostino et al. Trends in cardiovascular complications of diabetes. JAMA 292, 2495–2499 (2004). https://doi.org/10.1001/JAMA.292.20.2495

3. E.L.M. Barr, P.Z. Zimmet, T.A. Welborn, D. Jolley, D.J. Magliano, D.W. Dunstan et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116, 151–157 (2007). https://doi.org/10.1161/CIRCULATIONAHA.106.685628.

4. A.D. Kaze, P. Santhanam, S.K. Musani, R. Ahima Echouffo-Tcheugui J.B. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study. J Am Heart Assoc. 10 (2021) https://doi.org/10.1161/JAHA.120.016947.

5. American Diabetes Association, Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 45, S144–S174 (2022). https://doi.org/10.2337/DC22-S010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Cardiovascular Disease Risk in Patients with Type 2 Diabetes Mellitus Using Clinical Laboratory Markers;Journal of Clinical Medicine;2024-06-18

2. Lipid metabolism disorders in patients with type 2 diabetes mellitus: focus on hypertriglyceridemia;FOCUS. Endocrinology;2024-05-13

3. Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17;DARU Journal of Pharmaceutical Sciences;2023-10-17

4. Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome;Diseases;2023-10-13